We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Fortrea Holdings Inc (FTRE) USD0.1

Sell:$26.92 Buy:$26.95 Change: $0.84 (3.20%)
NASDAQ:1.03%
Market closed |  Prices as at close on 26 July 2024 | Switch to live prices |
Sell:$26.92
Buy:$26.95
Change: $0.84 (3.20%)
Market closed |  Prices as at close on 26 July 2024 | Switch to live prices |
Sell:$26.92
Buy:$26.95
Change: $0.84 (3.20%)
Market closed |  Prices as at close on 26 July 2024 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Fortrea Holdings Inc. is a global contract research organization (CRO), which provides clinical development solutions to the life sciences industry. The Company is engaged in providing biopharmaceutical product and medical device development services to pharmaceutical, biotechnology and medical device customers. The Company offers customers flexible delivery models that include full service, functional service provider, and hybrid service structures. It provides phase I-IV clinical trial management, clinical pharmacology and consulting services. The Company manages its business through a single segment, Clinical Services, that provides services across the clinical pharmacology and clinical development spectrum. The Company has access to all key markets worldwide through a footprint of primary office locations in five countries (the United States, the United Kingdom, China, India and Singapore) with field operations in other jurisdictions worldwide.

Contact details

Address:
8 Moore Drive
DURHAM
27709
United States
Telephone:
+ ()
Website:
https://www.fortrea.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
FTRE
ISIN:
US34965K1079
Market cap:
$2.28 billion
Shares in issue:
89.40 million
Sector:
Life Sciences Tools & Services
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
NASDAQ Comb. Composite

Key personnel

  • Thomas Pike
    Chairman of the Board, Chief Executive Officer
  • Jill Mcconnell
    Chief Financial Officer
  • Mark Morais
    Chief Operating Officer President - Clinical Services

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.